Dr. Lal Pathlabs Limited — Major Shareholding Notification 2020

May 20, 2020

May 19, 2020

The Company Secretary Dr. Lal PathLabs Limited Block-E, Sector-18, Rohini New Delhi-110085

Sub: Disclosure under Regulation 30 and 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Dear Sir,

Please find attached disclosure as required under Regulation 30 and 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for your records.

Thanking You,

Yours Faithfully,

$\sqrt{a}$ da

Dr. Vandana Lal Promoter & Whole-Time Director Dr. Lal PathLabs Limited

Encl: As above

CC:

National Stock Exchange of India Limited BSE Limited Exchange Plaza, Plot No. C/1, G Block, Bandra Kurla Complex Bandra (E)-Mumbai - 400 051. Symbol: LALPATHLAB

Corporate Relationship Department Phiroze Jeejeebhoy Towers Dalal Street Mumbai- 400001

Stock Code: 539524

ž,

ANNEXURE-1

Disclosure under Regulation 30 SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Part - A - Details of Shareholding

$\ddot{z}$

1.	Name of the Target Company(TC)	Dr. Lal PathLabs Limited
2.	Name of the stock exchange(s) wherethe shares of the TC are listed	BSE Limited		The National Stock Exchange of India Limited &
3.	Particulars of the shareholder(s):
a.	Name of the person(s) together withPersons Acting in Concert (PAC)whose total holding (including that inthe form of shares, warrants,convertible securities and any otherinstrument that would entitle theholder to receive shares in TC) ismore than 25% of the voting rights ofthe TG;	N.A.
$-58$	Or
b.	Name(s) of promoter(s), member ofthe promoter group and PAC with him	1. (Hony) Brig. Dr. Arvind LalDr. Vandana Lal$2^{\circ}$3.Dr. Archana Lal ErdmannMr. Anjaneya Lal4.
$\overline{4}$	Particulars of the shareholdingofperson(s) mentioned at (3) aboveAs of March 31, 2020:	Numbershares	of $\frac{9}{6}$ w.r.t. totalshare / votingcapitalwhereverapplicable	$\frac{0}{0}$totalofdiluted share/voting capital ofTC
A	Shares
i	(Hony) Brig. Dr. Arvind Lal	2,69,80,443	32.37	32.37
ii	Dr. Vandana Lal	1,66,84,422	20.02	20.02
iii	Dr. Archana Lal Erdmann	19,63,751	2.36	2.36
iv	Mr. Anjaneya Lal	16,89,614	2.03	2.03
B	Voting Rights (otherwise than byshares)	Nil	Nil	Nil
C	Warrants	Nil	Nil	Nil
D	Convertible Securities	Nil	Nil	Nil
E	Any other instrument that wouldentitle the holder to receive shares inthe TC	Nil	Nil	Nil
	Total	4,73,18,230	56.77	56.77

$Part - B$

Name of the Target Company: Dr. Lal PathLabs Limited

Name(s) of the person andPersons Acting in Concert (PAC)with the person	Whether the personbelongs to Promoter/Promoter group	PAN of the person andPACs
1. (Hony) Brig. Dr. Arvind Lal	Promoter
2. Dr. Vandana Lal	Promoter
3. Dr. Archana Lal Erdmann	Promoter Group
4. Mr. Anjaneya Lal	Promoter Group

Disclosure under Regulation 31(4) SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

I hereby confirm that I along with the members of Promoter/Promoter group/ person acting in concert (PAC), have not made any encumbrance, directly or indirectly, over the shares of the Company during the Financial Year ended on March 31, 2020.

Kindly take note of the same for your records.

Thanking You,

Yours Faithfully,

$\Omega$

Dr. Vandana Lal Promoter & Whole-Time Director Dr. Lal PathLabs Limited

. ..